Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  IGI LABORIGI       

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 66,9 M
EBIT 2016 4,47 M
Net income 2016 -9,49 M
Debt 2016 48,8 M
Yield 2016 -
Sales 2017 91,2 M
EBIT 2017 10,9 M
Net income 2017 -2,55 M
Debt 2017 72,1 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales2016 6,51x
EV / Sales2017 5,03x
Capitalization 387 M
More Financials
Company
Teligent, Inc. develops, manufactures and markets topical formulations.The company sells generic topical pharmaceutical products under IGI label.It also provides development, formulation, and manufacturing services to the pharmaceutical, over-the-counter and cosmetic markets.The company's products... 
Sector
Pharmaceuticals
Calendar
03/07Earnings Release
More about the company
Surperformance© ratings of IGI LABORIGI
Trading Rating : Investor Rating :
More Ratings
Latest news on IGI LABORIGI
11/30 TELIGENT, INC. : Announces FDA Approval Of Clobetasol Propionate Lotion 0.05%
11/16 TELIGENT : Ranked 200 Fastest Growing Company in North America on Deloitte's 201..
11/16 TELIGENT, INC. : Ranked 200 Fastest Growing Company in North America on Deloitte..
11/16 TELIGENT, INC. : To Present At 7th Annual Craig-Hallum Alpha Select Conference O..
11/08 TELIGENT : Management's Discussion and Analysis of Financial Condition and Resul..
10/28 TELIGENT : reports 3Q loss
10/27 TELIGENT, INC. : Results of Operations and Financial Condition, Financial Statem..
10/27 TELIGENT, INC. : Announces Third Quarter 2016 Results
10/14 TELIGENT, INC. : To Hold Conference Call For 3rd Quarter 2016 Results
10/11 TELIGENT : Announces The Opening Of A Product Development Laboratory In Estonia
More news
Sector news : Pharmaceuticals - NEC
12/07 MYLAN : EpiPen maker Mylan to restructure, cut workforce
12/07DJABBOTT LABORATORIES : Seeks to Terminate Alere Deal -- Update
12/07DJPFIZER : Fined $107 Million for Overcharging U.K. for Epilepsy Drug
12/07DJABBOTT LABORATORIES : Seeks to Terminate Alere Deal
12/07DJMARKET SNAPSHOT : Dow, S&P 500 Set Intraday Records, But Health-care Slumps On T..
More sector news : Pharmaceuticals - NEC
Advertisement
Chart IGI LABORIGI
Duration : Period :
IGI LABORIGI Technical Analysis Chart | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 9,75 $
Spread / Average Target 34%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Jason Grenfell-Gardner President, Chief Executive Officer & Director
James Charles Gale Chairman
Sanjay Samudre Operations Director
Jenniffer L. Collins CFO, Secretary & Head-Investor Relations
Stephen Richardson Chief Scientific Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
IGI LABORIGI89.51%387
JOHNSON & JOHNSON9.09%304 863
PFIZER INC.-2.23%191 517
ROCHE HOLDING LTD.-19.65%190 397
NOVARTIS AG-20.79%180 387
MERCK & CO., INC.14.12%166 200
More Results